Acurx Pharmaceuticals, Inc. (ACXP)
NASDAQ: ACXP · IEX Real-Time Price · USD
2.470
+0.040 (1.65%)
Jul 22, 2024, 10:01 AM EDT - Market open
Acurx Pharmaceuticals Employees
Acurx Pharmaceuticals had 4 employees as of December 31, 2023. The number of employees did not change compared to the previous year.
Employees
4
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
n/a
Profits / Employee
-$4,013,175
Market Cap
39.24M
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 4 | 0 | - |
Dec 31, 2022 | 4 | 1 | 33.33% |
Dec 31, 2021 | 3 | 0 | - |
Dec 31, 2020 | 3 | - | - |
Related Stocks
Company Name | Employees |
---|---|
Nortech Systems | 775 |
Concord Medical Services Holdings | 727 |
electroCore | 68 |
Aligos Therapeutics | 66 |
Curis | 49 |
Ocean Biomedical | 9 |
ProMIS Neurosciences | 7 |
ACXP News
- 5 days ago - USPTO Grants Acurx Pharmaceuticals New Patent for Ibezapolstat to Treat CDI While Reducing Recurrence of Infection and Improving Health of the Gut Microbiome - PRNewsWire
- 6 days ago - Acurx Pharmaceuticals, Inc. to Discuss Second Quarter 2024 Financial Results on August 9, 2024 Conference Call and Provide Business Update - PRNewsWire
- 7 days ago - Acurx Pharmaceuticals Announces Presentation of Ibezapolstat Phase 2 Clinical Trial Results for CDI at Scientific Conference - PRNewsWire
- 2 months ago - Acurx Announces Successful FDA End-of-Phase 2 Meeting and Phase 3 Readiness for Ibezapolstat in the Treatment of C. difficile Infection - PRNewsWire
- 2 months ago - Acurx Pharmaceuticals, Inc. Reports First Quarter 2024 Results and Provides Business Update - PRNewsWire
- 2 months ago - Acurx Pharmaceuticals Announces Presentation of Ibezapolstat Phase 2 Clinical Trial Results at ESCMID Global 2024 Scientific Conference - PRNewsWire
- 3 months ago - Acurx Pharmaceuticals Announces Presentation of Ibezapolostat Phase 2 Clinical Trial Results at upcoming ESCMID 2024 Scientific Conference - PRNewsWire
- 3 months ago - Acurx Pharmaceuticals, Inc. to Discuss First Quarter 2024 Financial Results on May 15, 2024 Conference Call and Provide Business Update - PRNewsWire